Subsequent to the first report in the 1940s on incubation of tissue sections with fluorescein-conjugated antibodies for localization of antigens, a great number of modifications were introduced to improve the validity of immunohistochemistry which has become a growingly popular tool. The use of immunoenzymatic techniques eliminates the need for expensive fluorescence microscopy equipment, the lack of permanency of preparations and the lack of electron density required in ultrastructural localization of antigens. Regardless of the technique, it is also important to choose a correct fixation which allows the proper preservation of antigens and morphology and the penetration of antibodies through the entire thickness of the preparation. A variety of immunohistochemical techniques have been applied to study several components of the lung, such as collagen, surface active material, lung specific antigens, and enzymes and the detection of tumor markers, immunoglobulins and infectious agents in the respiratory system which is reviewed. The large surface area and the multiplicity of cell types provided by the respiratory tract epithelium of humans for exposure to microbial as well as toxic substances in the environment make this organ system very vulnerable but a good early indicator of adverse health effects. Immunohistochemistry provides valuable information complementary to the immunochemical and biochemical characterization of this barrier.
Introduction
In recent years immunohistochemistry (IHC) has become an increasingly popular and effective tool in research and diagnostic laboratories. The manifest success of this method is due to technological improvements, increased availability of purified antigens, antisera, and other reagents, and the accumulation of practical experience in a variety of applications. IHC combines the advantages of the high specificity and affinity of antibodies in recognizing tissue antigens with the high topographical resolution of light and electron microscopy. It can thus provide information which would be difficult or impossible to obtain by other techniques (1) (2) (3) (4) (5) (6) .
Applications of IHC have contributed significantly to our knowledge about the distribution and pathological reactions of several components of the lung such as collagen, surface active material, lung-specific antigens, and enzymes; the method has also been applied to the detection of tumor markers, immunoglobulins, and infectious agents in the respiratory system. The first part of this review will deal with general principles of IHC techniques, while the second part will discuss particular applications relevant to pulmonary physiology, pathology and toxicology.
Immunohistochemical Techniques Development of Immunohistochemical Techniques
The origin of the IHC techniques goes back to the early 1940s when Coons et al. (7) reported that fluorescein-conjugated antibodies were useful in demonstrating bacterial antigens in infected tissue. The simple principle of this "direct" technique is schematically illustrated in Figure 1A . The method involved a single incubation ofthe tissue preparations with the fluoresceinconjugated antibodies directed against the antigen to be localized. Subsequently this original technique underwent many modifications, all aimed at improving its practicability and efficiency. The first major innovation (8) eliminated the need for conjugating each individual antiserum with the fluorescent dye by using unconjugated antibodies in the first step, followed by a secondary conjugated antibody directed against the immunoglobulins of the species from which the first or primary antiserum was derived (two-layer, sandwich or indirect technique) (Fig. 1B) . For example, rabbit antiserum to the antigen is followed by fluoresceinconjugated sheep anti-rabbit gammaglobulin. Since the latter antibodies recognize determinants common to all rabbit IgG molecules (Fc region), a single conjugated reagent can be used for the localization of any number of tissue antigens as long as suitable rabbit primary antiserum is available. In addition, since several molecules of the labeled antibodies can bind to one molecule of primary antibody (a feature not shown in Fig. 1 ), substantial amplification of the staining is achieved. This technique is still used today with good success in many laboratories throughout the world. However, difficulties in preparing effective conjugates, the need for expensive fluorescence microscopy equipment, frequent incidences of disturbing background fluorescence, the lack of permanency of the resulting preparations, and the lack of electron density of the fluorescent label have all combined to stimulate the search for more convenient and versatile labels. The first such "substitute" label was ferritin (9) , which is still popular since it permits high resolution at the electron microscope level. Ferritin can be used as a label chemically conjugated to the primary or secondary antibodies instead of fluorescein, as in Figure 1A or 1B. It can also be used as part of a more efficient ferritin bridge (10) , to be discussed later. Several enzyme labels were suggested and among these horseradish peroxidase (HRP) emerged as the most popular (11, 12) . This enzyme, when used with suitable substrates (13, 14) , produces colored reaction products which are properly localized, stable, and electron dense, permitting ordinary light microscopy as well as electron microscopy. Other enzymes are also being used with good results with the various methods represented in Figure 1 : acid phosphatase (15) , alkaline phosphatase (11), glucose oxidase (16, 17) , and smaller hemelike molecules with peroxidase activity (18) (19) (20) (Petrusz, unpublished) . Trypsin (49), pepsin (53), and pronase (47) have all been recommended, and the required conditions seem to vary with both the methods of tissue processing and the enzyme used. As pointed out by Curran and Gregory (46), pretreatment with proteolytic enzymes permits the use of much higher dilutions of the primary antisera, thus reducing nonspecific background and staining of unwanted antigens (see below).
Criteria of Validity
Performing IHC staining is relatively easy, but correct interpretation of the results presents some unusual problems. Interpretation should be based on generally accepted criteria of validity. Such a set of criteria, including efficiency, accuracy, precision, sensitivity and specificity, have been proposed by Petrusz et al. (54) . These criteria have been defined and procedures have been outlined whereby IHC staining can be improved and the results interpreted in terms of these criteria. Among the proposed criteria of validity only two, efficiency and specificity, will be discussed here, since these are the most essential ones and have direct bearing on the performance and interpretation of IHC staining. For further details, the reader is referred to other publications (2, (4) (5) (6) 54, 55) .
Efficiency
Efficiency in IHC staining is defined as the signal-tonoise ratio in a stained preparation. Clearly, the improvements represented in Figure 1 from A to F are all aimed at maximizing the signal, i.e., the quantity or intensity of label attached to a given antigenic site in the tissue. Efficiency may also be improved by facilitating the binding of the primary antibody to the tissue antigen (extended incubation time, low ionic strength buffer, close to neutral pH detergents in buffer) and by taking effective steps to reduce any possible background staining. The latter can be achieved by saturating nonspecific binding sites with proteins from normal sera, by using purified antisera if necessary, and in general by adjusting the conditions of all incubations to favor specific but to prevent nonspecific binding. Efficiency may be improved by treating sections with proteolytic enzymes prior to immunostaining. Optimal efficiency in a given system is best found by titration, determining the dilution of the primary antiserum which produces maximum specific staining without nonspecific background. Naturally, a prerequisite of this procedure is prior rigorous standardization of all other steps involved in the particular technique used. Such standardization and titration should precede all definitive IHC work.
Specificity
Two fundamental sources of nonspecifi city have been defined in IHC staining: method nonspecificity and antibody nonspecificity (5, 55) . This approach to specificity is useful because it is generally valid for all IHC techniques and it offers relatively simple practical guidelines to solve or prevent actual problems of nonspecificity.
Method nonspecificity essentially includes all staining that commonly would be described as "artifact'" It may arise from binding to the tissue of any other staining component than the primary antibody (e.g., proteinprotein interactions) (56) (60, 63) , in erythrocytes and leukocytes trapped in the rich vascular system (64), on surfaces of alveolar cells (64) , and in epithelial cells lining the bronchial tree (64, 65) . Unless proven otherwise, it should be assumed that such enzymatic activity survives the fixation and embedding procedures commonly employed. Endogenous peroxidase can be (1) tolerated if it is known and not disturbing, (2) inactivated by any of several available methods before immunostaining (1, 59, (66) (67) (68) , or (3) reacted with a substrate producing different color than that used for the immunostaining (69) .
The ultimate question to be answered in every IHC staining is the question of antibody specificity: how confident can one be concerning the identity of the tissue antigen localized. From this point of view, IHC does not differ from other immunochemical systems: the specificity of the antibodies responsible for a given IHC staining can only be defined by studying the interaction of these antibodies with known antigens of high purity. However, IHC methods per se are not based on competitive interactions such as, e.g., radioimmunoassay (RIA). In RIA only those antibodies will be operative which recognize (bind) the radioactive tracer; all other antibody populations present in the antiserum can be excluded from consideration. In IHC, all antibody populations which find a complementary antigenic site in the tissue will bind and produce staining. Consequently, inhibition of the IHC staining with known and pure antigens (absorption) is the only direct method to gain information on the specificity of the staining, i.e., on the identity of the antigen localized. This information is not absolute, since it evidently refers only to the antigenic site and not to the entire molecule of the antigen. When an antigenic site occurs as a partial sequence in two or more larger molecules (a frequent possibility), it is clear that the absorption test alone will not be sufficient for identification of the tissue antigens stained. (It should be noted that this as well as most of the previous arguments apply to both conventional and monoclonal antibodies.) In such cases, one possible recourse is to search for antisera which might recognize a different portion of the antigen not shared with other molecules. Otherwise IHC results must be supported by physiological or biochemical data concerning the identity of the antigen localized.
Absorption or "blocking" is usually done by combining known amounts of the antigens with working dilutions of the primary antiserum. If the antigen binds to the sites that are critical for immunostaining, subsequent staining will be blocked or inhibited. Since the tissue antigen is in insoluble phase, it will be favored by the antibodies versus the antigen added in soluble form; therefore, it may be necessary actually to remove antibodies from the solution, either by creating suitable conditions for the formation of an insoluble precipitate, or by using antigen coupled to insoluble carrier particles. Similar liquid or solid phase systems may also be used to assess cross-reactivities of antisera and to purify antisera by removing unwanted antibody populations. Further theoretical and practical questions concerning specificity and other criteria of validity have been discussed elsewhere (54, 55) .
Interpretation of Staining
The great popularity of IHC techniques leaves no doubt about their usefulness and practicability However, for correct interpretation of the results it is extremely important to follow certain routine rules of standardization and to perform all necessary controls. In our view, method specificity in most cases should be practically absolute, with only very few exceptions (e.g., peroxidaselike activity in blood cells when specific staining is clearly separated from the vascular compartment). The method, including the enzyme-substrate reaction, should be standardized so that conditions are optimal and do not vary from one staining to the next. This will ensure reproducible results when identical materials are used. Titration should establish the optimal dilution of the primary antiserum and no staining should be present at extremely high dilutions (method specificity). Antibody specificity should be evaluated by at least one of the available absorption procedures and addition of excess antigen should inhibit the staining. Moreover, any additional other evidence (physiological, biochemical, pathological) should be sought and evaluated to support the validity of the conclusions drawn from IHC results.
Immunohistochemistry of Specific Components of the Lung Collagen
In much of the early immunochemical work on extracellular sites of collagen and reticulin, which is not reviewed here, it was difficult to assess the role of contaminating antigens, particularly serum proteins. However, in 1969 Nagasawa and Shibata (70) found immunofluorescence in human alveolar capillary basement membrane with fluorescein-labeled antiserum to human glomerulal basement membrane. Engel and Catchpole in 1972 (71) demonstrated immunofluorescence in alveolar walls and in the lamina propria of the airways in the rat using a specific antiserum against rat tail collagen. The antibody reacted with several forms of isolated collagen but not with rat serum. Basement membranes and reticular fibers of other organs were also stained.
Subsequently, purified antibodies to distinct types of interstitial collagens and procollagens (types I, II, and III) were used for a qualitative survey on distribution of various collagens in many IHC studies on healthy as well as diseased tissues (72) . Purified antibodies against both human and mouse type IV collagen reacted in indirect immunofluorescence tests with basement membranes in various human and mouse tissues including the lung (73) . The findings indicated that various basement membranes might contain related or identical collagenous proteins with a high degree of interspecies homology. All types of collagen (types I, II, III, IV and AB2 or V) have been found in the lung (74) . In an immunofluorescence study of pulmonary fibrosis with affinity-purified antibodies in 1980, Madri and Furthmayr (74) assessed the relative amounts of collagens in different locations. TIype I collagen was markedly increased in alveolar septae, type III was markedly reduced and observed only perivascularly, type V was considerably increased in the interstitium and located in areas of smooth muscle cell proliferation. No change was noted with type IV collagen. These IHC results were consistent with the results obtained with various other methods such as dissection, isolation and compositional analysis.
The previously cited IHC work on collagen of the lung was performed on fresh frozen material with fluorescein label. But there is cumulative evidence that at least collagen type IV antigenicity is preserved through conventional formaldehyde-fixation and paraffin processing (75, 76) . Ultrastructural localization of a soluble collagen antigen (77) and type IV antigen (78) was obtained in the trachea of chick embryos and endothelial cells of gums, respectively, by a post-embedding immunoperoxidase technique. At the time of preparing this article immunoelectronmicroscopical studies on collagen synthesis in the lung were not available. In the future they may provide useful information on the pathogenesis of pulmonary fibrosis which composes 20% of the noninfectious diseases of the lung, and is often associated with drugs or toxic substances.
Surface-Active Material
Following the discovery in 1958 of the surface-active lipoprotein layer, so-called surfactant, that forms the interface between gas and liquid in the alveoli (79) , the demonstration of the material was dependent upon the surface tension lowering effects of lung extracts until an IHC study by Craig (80) . In 1964 he obtained an antiserum to washed foam from autopsied human lungs that did not cross-react with human serum proteins and was localized by fluorescence microscopy on the alveolar walls of human lungs. Since all commonly used fixatives dissolved the antigen from specimens, he mainly used unfixed cryostat sections for his study on the distribution of surface-active material in the lungs of infants with and without respiratory distress. He described the progression from intracellular to both intracellular and alveolar, and then to solely alveolar localization, of the specific antigenic protein during the gestation period.
In a number of immunochemical analyses, different preparations of surface-active material were found also to contain serum protein antigens (81 (102), pointing to the role of the enzyme as an antibacterial agent (103) . In respiratory tissue, lysozyme was localized with the immunoperoxidase technique on formalin-fixed paraffin sections (92, 104) in alveolar macrophages, Type II pneumocytes, ciliary layer of the trachea and in secretory cells in laryngotracheal glands in various rodents and man. Specific staining was obtained with rabbit anti-rat lysozyme or anti-human urinary lysozyme antibodies but not with antibodies against egg white lysozyme. Interestingly, the respiratory system of the hamster, which is a useful experimental animal due to its relatively low pulmonary infection rate (105), seemed to be devoid of the lysozyme based on immunohistochemical as well as biological activity studies (101) . As an interpretative caution,-Spicer et al. (101) tested different fixatives and the specificity of the IHC staining in lung. In their thoroughly controlled system, laryngotracheal serous cells still possessed an unexplained, selective property of (nonimmune) binding of immunoglobulin. Such binding was also noted in mast cells (61) . However, Bowes et al. (106) reported specific ultrastructural localization of lysozyme in serous cell FIGURE 2. Localization of a unique glycoprotein in the alveolar Iyrpe II cells of the rat lung (immunoperoxidase-bridge method) (26) . Arrows point to dark precipitate in the alveolar walls associated with a specific antibody (a gift from Dr. S. N. Bhattacharyya) to the 36,000 molecular weight glycoprotein which was purified from lamellar bodies (94) (95) (96) . A formalin-fixed 6 ,um thick paraffin section counterstained with toluidine blue x 1300. granules in human bronchial glands. In comparative studies of lysozyme between conventionally reared and germ-free rats (107), IHC was of limited value, but proved to be very useful in an ontogenic study of the enzyme (108, 109) .
Pulmonary Monooxygenase Enzymes
The cytochrome P-450-dependent monooxygenase system, which metabolizes endogenous as well as foreign compounds, is also present in the lung (110) , although at a lower concentration than in the liver. Recent IHC localization of cytochrome P-450 isoenzymes and NADPH-cytochrome P-450 reductase in specific cell types of the lung such as in Clara cells and Tlype II pneumocytes probably reflects the fact that these enzymes are present in cells in high enough concentrations to be involved in organ specific carcinogenesis or toxicity (111) (112) (113) (114) . The antigenicity of cytochrome P-450 (Fig. 3) is retained after paraffin embedding of paraformaldehyde-fixed tissues (113, 114) . IHC provided valuable information complementary to the immunochemical and biochemical characterization of pulmonary monooxygenase system (115) . With regard to sensitivity, IHC techniques are likely to be superior to conventional histochemistry, allowing better cellular and subcellular resolution. However, the method requires at least partial purification and characterization of the enzyme of interest, which is not always feasible. Also, immunoreactivity does not necessarily reflect the presence of biologically active enzyme.
Angiotensin-Converting Enzyme in Pulmonary Endothelial Cells
Angiotensin-converting enzyme is a mammalian peptidase which metabolizes circulating bradykinin and catalyzes the change of angiotensin I to angiotensin II, the vasoactive agent of the renin-angiotensin system. Bradykinin and angiotensin I are metabolized during their passage through the vasculature of the lung. Ryan et al. (116) demonstrated with IHC that the converting enzyme was actually localized along the luminal surface of pulmonary endothelial cells. For pre-embedding ultrastructural localization the authors used the anticonverting enzyme antibody coupled to microperoxidase on glutaraldehyde or, preferably, paraformaldehydepicric acid-fixed tissue (117) . The strategic location suggested that the enzyme might help regulate the entry of bradykinin and angiotensin II into the systemic arterial circulation. Furthermore, this regulation could easily suffer from diseases that specifically damage the pulmonary endothelium as demonstrated with IHC techniques in Rocky Mountain spotted fever (118) .
The converting enzyme, localized by immunofluorescence, appeared as a good marker for studying the development of the pulmonary vascular bed in rabbits (119) which has been used as a marker for capillary (125) or epithelial (126) permeability. A glycolytic neuron-specific enolase isoenzyme, which was originally extracted from bovine brain (127) , was recently demonstrated in neuroendocrinelike cells of fetal lung using IHC (128) . Neuron-specific enolase has also been found in other endocrine (APUD or "amine precursor uptake and decarboxylation") cells of the central and peripheral divisions of the diffuse neuroendocrine system (129) . This isoenzyme can provide the capability of using the same IHC marker to delineate various autonomic (e.g., adrenergic, cholinergic and peptiderdic) nerves in the lung as well as different pulmonary neuroendocrine cells, which with IHC have been shown to contain for instance calcitonin (130) , and bombesin (131, 132) (Fig. 4) . In addition to enzymes, protease inhibitors have been localized by IHC in the respiratory system (133, 134) .
Markers of Lung Tumors
When the concept of IHC tumor markers was generated, it was hoped that a marker would be identified for each histologic type. Unfortunately, that goal has not been realized (135, 136) . Carcinoembryonic antigen (137) , which was first discovered in extracts of colonic tumor (138) , was found in 20 to 30% of bronchial squamous cell carcinoma or lung adenocarcinomas by IHC (139, 140) . The IHC localization of intracellular keratin appeared helpful in establishing the epithelial nature of poorly differentiated neoplasms, but in a preliminary survey, primary lung tumors could not be classified by keratin content (141) .
Human chorionic gonadotropin and immunoreactive growth hormone were localized in bronchogenic carcinomas with immunofluorescence (142, 143) . These hormones have been associated mainly with large cell carcinomas and adenocarcinomas of the lung (144) . In an IHC study of 29 oat cell carcinomas of the lung, Deftos (145) demonstrated the presence of calcitonin, 1-endorphin or ACTH in all but three tumors. The IHC localization of histaminase (146) as well as selected polypeptide hormones, such as bombesin (147) , in small cell carcinoma of the lung revealed that within each tumor different cells contained different amounts of the compound.
Bell used IHC to demonstrate an antigen highly associated with oat cell carcinoma and undetectable in normal adult tissue (148) . The antigen was also characteristic of certain normal neural crest-derived cells in the peripheral nervous system (149) . The IHC localization of the antigen was further correlated with the presence of cytoplasmic neurosecretory granules (150) .
In addition to this, neuron-specific enolase appeared as a good marker for oat cell carcinomas of the lung as well as for other neuroendocrine tumors (151) . These markers allow advance morphological investigations on small cell carcinomas and other lung tumors that have recently demonstrated to be quite heterogeneous with regard to cellular composition (152, 153 (174) performed an interesting experiment where bronchial and intestinal lamina propria of rabbits was repopulated with IgA-containing cells after transfer of homologous bronchial and Peyer's patch lymphocytes. Direct fluorescence on formalin-fixed cryostat sections was used as described by Bienenstock et al. (175) . The immunoperoxidase technique on alcoholfixed paraffin sections was applied in studies of the respiratory tract immune system in the pig (176, 177) and in sheep (178, 179) . In sheep, IgM was the main immunoglobulin seen by immunofluorescence and peroxidase techniques in the nasal and bronchial glands before suckling; after suckling also IgG was found at all levels of respiratory tract. In adult sheep, IgA became the major locally appearing immunoglobulin of the respiratory system. Alley et al. (178) suggested that immature epithelial cells such as those found in proliferative areas of diseased airways would be actively engaged in immunoglobulin transport.
Response to Infections
Immunoglobulin production in lungs of hamsters experimentally infected with Mycoplasma pneumoniae was studied by Fernald et al. (180) with indirect immunofluorescence in acetone-fixed cryostat sections.
In control lungs only IgA-containing plasmacytes were found, but during the infection varying numbers of cells which also contained other immunoglobulins, infiltrated the peribronchial spaces. Non-immunoglobulin-stainable lymphocytes increased in number, too. However, it is important to recognize clinically silent infections such as caused by Mycoplasma pulmonis in rats, since they may significantly change the results of IHC studies on respiratory system immunity in laboratory animals (181) .
Immunological Reactions
With direct immunofluorescence on unfixed cryostat sections obtained from asthmatic patients through autopsy or surgery Gerber et al. (182) demonstrated that IgE was present in the bronchial epithelium and along the basement membrane. IgE was observed in the bronchial glands of all patients with asthma and to a lesser degree of many patients with chronic bronchitis or normal bronchi. IgE was not detected in mast cells. The presence and distribution of other immunoglobulins did not differ from that in normal bronchi. In patients with lung cancer Zeromski et al. (183) found large amounts of immunoglobulins in plasma cells with a predominance of the IgA and IgG classes.
l'ype II immune reactions have been thought to be involved in several so-called diffuse lung diseases, where the presence of immune complexes was verified by IHC. In procainamide-induced systemic lupus erythematosus specific nuclear fluorescence with deposition of either IgG or IgM and also C3 was found in pleura by direct immunofluorescence (184). Churg et al. (185) , using formaldehyde-fixed paraffin sections, found IgG in alveolar walls and vessels of a patient with systemic lupus erythematosus. This was in agreement with studies of Inoue et al. (186) who were able to demonstrate granular deposits of IgG, complement (C3) and DNA in the alveolar walls and in the alveolar capillary walls in systemic lupus erythematosus pneumonitis. In rheumatoid lung both IgM and IgM-rheumatoid factor complexes as well as IgG were localized in alveolar walls, vessels and adjacent to rheumatoid nodules (187, 188) . In IHC studies on Goodpasture's syndrome, which is characterized by development of antibodies to alveolar and glomerular basement membrane antigens, IgG and complement (C3) were localized both in alveolar walls in the lung and in glomerular basement membranes of the kidney (189) (190) (191) ). An experimental model sharing these features and thus resembling Goodpasture's syndrome was developed by injecting rabbit anti-rat lung serum into normal rats (192) . Based on immunofluorescence, Levy et al. (193) reported an example of autoimmune disease characterized by the presence of antitubular and antialveolar basement membrane antibodies associated with immune-complex glomerulonephritis. In this study both human and rat lungs were used in order to demonstrate indirect immunofluorescence with the patient's serum.
Farmer's lung or allergic alveolitis' also belongs to diffuse lung diseases which involve typie II and possibly Arthus-type reactions. The main source of sensitizing agents for this disease are Miropolyspora faeni and Thermoactinomyces vulgaris, and the IHC studies with patients' antisera were able to include the localization of the causative agents (194) . Although the most consistent finding was a diffuse interstitial pneumonitis, the walls of the bronchioles appeared rich in antigen when the immunofluorescence technique on acetone-fixed cryostat sections was used (195) . The lungs showed great numbers of fluorescing histiocytelike cells with anti-C3 complement, suggesting the antecedent presence of antigen-antibody complexes. In an immunofluorescent study on bovine hypersensitivity pneumonitis, also caused by M. faeni, Wilkie et al. (196) found that pretreatment of frozen sections with pH 2.8 glycine-HCI buffer was a necessary prerequisite for specific staining for the antigen. The authors felt that the buffer 'unmasked" the antigen by effectively eluting antibodies bound to the antigen in vivo. Thus, routine immunofluorescent staining of M. faeni antigen in tissues of individuals with specific serum antibody titers may be inhibited by prior combination with the antibody. Antigens of M. faeni were located in apparent association with alveolar macrophages. In order to elucidate the pathogenesis of farmer's lung, a number of animal models were recently developed (197) . Schallibaum et al. (197) exposed rabbits intratracheally to enzyme I, which is a highly immunogenic esterase isolated from M. faeni. After repeated exposures, intracellular antigen, immunoglobulin and complement could be demonstrated in histiocytes by direct immunofluorescence on alcohol-fixed cryostat sections. The authors suggested that direct enzyme action might contribute to the farmer's lung type pneumonia in eliciting tissue damage.
Diagnosis of Diffuse Interstitial Lung Disease
So far immunofluorescence has found little application in diagnostic histopathology oflung tissue (198) (199) (200) though it has been very valuable in renal disease. Hogan et al. (201) studied small needle biopsy specimens from 30 subjects with signs of diffuse interstitial lung disease; immunofluorescence examination of biopsies from six cases yielded positive results. The authors evaluated their study critically and in their summary three points received general attention: (1) Eosinophils and macrophages frequently demonstrated nonspecific staining (45). To avoid such pitfalls, it was necessary to identify positively any particular fluorescing cell by staining the same section with hematoxylin and eosin after immunofluorescence was completed. (2) An alternative to ascertain that the antibody deposits were specific would be to demonstrate deposits of complement or antigen in relation to antibody. However, such an approach would be applicable only to a small group of uncommon pulmonary diseases (other than infections) with known causative agents. (3) The small proportion of positive results obtained in their study might indicate that immunologic processes were involved at only one stage in the progression of disease or of response to a wide range of injuries that often have no humoral immune background. Thus Hogan et al (201) concluded that the artifacts encountered in lung IHC render it difficult to obtain consistent results. Furthermore, the way in which the specimens are obtained may contribute to the difficulty. A needle biopsy, as in the study by Hogan et al. (201) may not provide enough proper material of the affected area. On the other hand, in autopsy material the amount of autofluorescence is often increased. Fortunately, in most of the cases, satisfactory material can be obtained through open lung biopsy.
Based on direct immunofluorescence on fixed and unfixed cryostat sections of idiopathic interstitial pneumonias, Schwarz et al. (202) suggested that immune complex deposition might play a role in pathogenesis and that once mural fibrosis supervened, these complexes (IgG and C3) were no longer demonstrable. Physiologic abnormalities appeared to correlate with the presence of fibrosis, which leads one to emphasize the results of the previously mentioned IHC studies on collagen (74) (205) (206) (207) . As an alternative to fresh or fresh-frozen material, formalinfixed paraffin sections can be used (205, 208) . Recently Suffin et al. (208) identified Legionella pneumophila in tissue sections by a new immunoenzymatic (glucoseoxidase) procedure (17) , that can be adapted to routine diagnostic practice.
Rickettsia rickettsii is typically difficult to demonstrate with histochemical stains (209, 210) 
Experimental Infections in Animals
In experimental work, IHC techniques have been often used to localize various infectious agents in the airways and lung in order to investigate in detail the routes of spread of specific micro-organisms. This has been correlated with conventional histopathological findings. In immunofluorescence studies on the pathogenesis of infection with influenza A virus in mice following exposure to aerosolized virus, Yielma et al. (217) came to the conclusion, in agreement with Lemercier et al. (218) , that viral replication happened earlier in the bronchi than alveoli. This appeared to be in disagreement with the findings of Denk and Kovac (219, 220) who claimed that after intranasal inoculation the replication started closer to alveolar sacs and later spread to the bronchi. Acetone fixed cryostat sections (217) , ethanol-fixed paraffin sections (218) and unfixed cryostat sections (219, 220) were used. Tada their method required antivirus antibody to be applied with fresh non-immune serum (containing complement) on acetone-fixed cryostat sections, and subsequent incubation with a fluorescent antibody against complement. Initial spread of virus, which was first located in reticular cells in the lung, was found to differ from that after intranasal inoculation of influenza virus (223 -226) . The course of herpesvirus infection was studied in rabbits (227) and in infant mice (228) by direct immunofluorescence on acetone-fixed sections. The influence of the route of administration of Newcastle disease virus on host response in chickens was studied by Beard and Easterday (229) with immunofluorescence. In domestic animals fluorescent antibody studies on parainfluenza 3 virus infections in lambs (230) and in enzootic pneumonia of pigs (231) Single organisms could be demonstrated and there was no nonspecific staining in the lung.
In an effort to further examine host response to infection, immunofluorescence was used to demonstrate the Newcastle disease virus in the brain and trachea, as well as globulins and specific antibody against the virus in mononuclear cells, mucous glands and mucus in tracheal mucosa of chickens which had been serially sacrificed during 1 to 120 days after infection (232) . A similar study on chronic pneumonia in swine with experimentally induced African swine fever was performed with antisera against viral antigen, porcine immunoglobulin, complement and fibrinogen on serial unfixed frozen sections (233) . The same approach was also applied to human autopsy material (142) . Localization of immunoglobulins in the lung has been discussed in the preceding section of our review.
In Vitro Models for Environmental Research
The large surface area provided by the respiratory tract epithelium of humans for exposure to microbial as well as toxic substances in the environment makes this organ system very vulnerable but a good early indicator of adverse health effects. However, the complexity of pulmonary defense mechanisms complicates definition of the interactive effects of pollutants and infectious agents. As a model, tracheal organ culture obtained from human fetuses as well as animals was utilized to maintain organized differential respiratory epithelium in vitro (234) . In this system Collier (234) used immunohistochemistry as a major tool for investigating the epithelial injury by Mycoplasma pneumoniae (Fig. 5) 
